QScreen AI Inc. develops artificial-intelligence health screening technology for clinical, correctional, occupational, and institutional settings. Company news centers on the QAI Platform, which combines physiological signals from a standard camera, passive voice analysis, and structured clinical intake workflows to support real-time screening and documented intake outputs.
Recurring updates cover platform integration, internal validation work, patent activity, commercialization efforts in North American institutional and workforce markets, strategic advisory and contractor relationships, and financing actions tied to deployment and working capital. The company also reports on clinical instruments used within its intake workflows, including CIWA-Ar, COWS, and C-SSRS.
PredictMedix Inc. (CSE:PMED)(OTCQB:PMEDF) has partnered with Versus Systems, Inc. to innovate tools for clinical trials, highlighted by a letter of intent signed on September 29. The partnership aims to integrate Versus’ rewards platform with PredictMedix’s remote patient monitoring technology, facilitating patient recruitment and compliance in clinical trials, a sector valued at approximately $40 billion. This initiative responds to the challenges posed by the COVID-19 pandemic, which emphasizes the need for remote patient monitoring and data integrity in clinical research.
Summary not available.
Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) has initiated the deployment of its COVID-19 symptom mass screening technology at Flow Water and a 24-hour pharmacy in Montreal. This partnership, outlined on August 17, 2020, aims to enhance health measures in essential businesses to mitigate COVID-19 risks.
The technology, implemented in collaboration with JUICEWORKS EXHIBITS, is designed to provide an extra layer of safety for employees and customers. The pharmacy's deployment is expected within 2-3 weeks, addressing health safety in a critical retail environment.
Predictmedix Inc. (CSE:PMED, OTCQB:PMEDF) announces the deployment of its COVID-19 and impairment screening technology at Indian Oil Corporation Ltd, a Fortune 500 company. The deployment will begin in 3-4 weeks, marking Predictmedix's entry into the Oil & Gas sector. Additionally, the company appointed Kiran Kumari to its advisory board for business development in the Asia Pacific region. Predictmedix also filed a US patent application for a healthcare provider reward management system, further enhancing its telehealth capabilities. The company aims to address health safety across workplaces.